The effect of bovine whey proteins on the ability of poliovirus and Coxsackie virus to infect Vero cell cultures

International Dairy Journal

Volumn 18, Issue 6, 2008, Pages 658-668

  Sitohy, Mahmoud ^a,b   Dalgalarrondo, Michèle ^a   Nowoczin, Marie ^c   Besse, Bernard ^c   Billaudel, Sylviane ^c   Haertlé, Thomas ^a   Chobert, Jean Marc ^a  

^a INRA   (France)

^b Zagazig University   (Egypt)

^c UNIVERSITÉ DE NANTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; ESTERIFICATION; RNA; VIRUSES;

ANTIVIRAL EFFICACIES; COXSACKIE VIRUS; ESTERIFIED PROTEINS;

PROTEINS;

BOVINAE; COXSACKIEVIRUS; HUMAN POLIOVIRUS 1; POLIOVIRUS;

EID: 43049178399     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2007.11.023     Document Type: Article

References (46)

1. Baker E.N. Lactoferrin three-dimensional structure: A framework for interpreting function. In: Shimazaki K., Tsuda H., Tomita M., Kuwata T., and Perraudin J.P. (Eds). Lactoferrin: Structure, function and applications (2000), Excerpta Medica, Elsevier, Amsterdam, The Netherlands 3-15
2. Beljaars L., Van Der Strate B.W.A., Bakker H.I., Reker-Smit C., van Loenen-Weemaes A., Wiegmans F.C., et al. Inhibition of cytomegalovirus infection by lactoferrin in vitro and in vivo. Antiviral Research 63 (2004) 197-208
3. Beljaars, L., van der Strate, B. W. A., Floris, R., Smit, C., Wiegmans, F. C., Molema, G., et al. (2001). Antiviral activity and mechanism of charged modified proteins on cytomegalovirus replication in vitro. In: Anti-cytomegalovirus applications of the intrinsically active drug carrier lactoferrin (pp. 69-90) 〈www.dissertations.ub.rug.nl/FILES/faculties/science/2001/〉, Dissertations of the University of Groningen [Chapter 4].
4. Berkhout B., Derksen G.C.H., Back N.K.T., Klaver B., de Kruif C.G., and Visser S. Structural and functional analysis of negatively charged milk proteins with anti-HIV activity. AIDS Research and Human Retroviruses 13 (1997) 1101-1107
5. Bertrand-Harb C., Chobert J.-M., Dufour E., and Haertlé T. Esterification of food proteins: Characterization of the derivatives by a colorimetric method and by electrophoresis. Sciences des Aliments 11 (1991) 641-652
6. Carrasco L. Modification of membrane permeability by animal viruses. Advances in Virus Research 45 (1995) 61-112
7. Chobert, J.-M., & Haertlé, T. (2003). Composition pour l'inactivation de particules virales et applications d'une telle composition. French patent # FR-03/06786.
8. Chobert J.-M., Sitohy M., Billaudel S., Dalgalarrondo M., and Haertlé T. Anti-cytomegaloviral activity of esterified milk proteins and L-polylysines. Journal of Molecular Microbiology and Biotechnology 13 (2007) 255-258
9. Cisani G., Varaldo P.E., Ingianni A., Pompei R., and Satta G. Inhibition of herpes simplex virus-induced cytopathic effect by modified hen egg-white lysozymes. Current Microbiology 10 (1984) 35-40
10. Cisani G., Varaldo P.E., Pompei R., Valisena S., and Satta G. Cell fusion induced by herpes simplex is inhibited by hen egg-white lysozyme. Microbios 59 (1989) 73-83
11. Cox S., Buontempo P.J., Wright-Minogue J., de Martino J.L., Skelton A.M., Ferrari E., et al. Antipicornavirus activity of SCH 47802 and analogues: In vitro and in vivo studies. Antiviral Research 32 (1996) 71-79
12. Halpin M.I., and Richardson T. Elected functionality changes of β-lactoglobulin upon esterification of side chain carboxyl groups. Journal of Dairy Science 68 (1985) 3189-3198
13. Harmsen M.C., Swart P.J., de Béthune M.P., Pauwels R., de Clercq E., The T.H., et al. Antiviral effects of plasma and milk proteins: Lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. Journal of Infectious Disease 172 (1995) 380-388
14. Jansen R.W., Molema G., Pauwels R., Schols D., De Clerq E., and Meijer D.K.F. Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins. Molecular Pharmacology 39 (1991) 818-823
15. Jiang S., Lin K., Strick N., Li Y.-Y., and Neurath A.R. Chemically modified bovine β-lactoglobulin blocks uptake of HIV-1 by colon- and cervix-derived epithelial cell lines. Journal of Acquired Immune Deficiency Syndromes 13 (1996) 461-462
16. Lu L., Hangoc G., Oliff A., Chen L., Shen R.N., and Broxmeyer H.E. Protective influence of lactoferrin on mice infected with the polythemia-inducing strain of Friend virus complex. Cancer Research 47 (1987) 4184-4188
17. Mailliart P., and Ribadeau Dumas B. Preparation of β-lactoglobulin and β-lactoglobulin-free proteins from whey retentate by NaCl salting out at low pH. Journal of Food Science 53 (1988) 743-752
18. Marchetti M., Pisani S., Antonini G., Valenti P., Seganti L., and Orsi N. Metal complexes of bovine lactoferrin inhibit in vitro replication of Herpes simplex virus type 1 and 2. BioMetals 11 (1998) 89-94
19. Marchetti M., Superti F., Ammendolia M.G., Rossi P., Valenti P., and Seganti L. Inhibition of poliovirus type 1 infection by iron, manganese and zinc-saturated lactoferrin. Medical Microbiology and Immunology 187 (1999) 199-204
20. Matthews T.H.J., Nair C.D.G., Lawrence M.K., and Tyrrel D.A.J. Antiviral activity in milk and possible clinical importance. Lancet 308 (1976) 1387-1389
21. McCann K.B., Lee A., Wan J., Roginski H., and Coventry M.J. The effect of bovine lactoferrin and lactoferricin B on the ability of feline calicivirus (a norovirus surrogate) and poliovirus to infect cell cultures. Journal of Applied Microbiology 95 (2003) 1026-1033
22. Monpoeho S., Dehee A., Mignotte B., Schwartzbrod L., Marechal V., Nicolas J.-C., et al. Quantification of enterovirus RNA in sludge samples using single tube real-time RT-PCR. BioTechniques 29 (2000) 88-93
23. Monpoeho A., Maul B., Mignotte-Cardiergues L., Schwartzbrod L., Billaudel S., and Ferré V. Best viral elution method available for quantification of enteroviruses in sludge by both cell culture and reverse transcription PCR. Applied and Environmental Microbiology 67 (2001) 2484-2488
24. Morens D.M., and Pallansch M.A. Epidemiology (of human enterovirus infections). In: Rotbart H.A. (Ed). Human enterovirus infections (1995), American Society for Microbiology, Washington, DC, USA 3-23
25. Neurath A.R., Debnath A.K., Strick N., Li Y.-Y., and Lin K. 3-Hydroxyphthaloyl-β-lactoglobulin. 1. Optimization of production and comparison with other compounds considered for chemoprophylaxis of mucosally transmitted human immunodeficiency virus type 1. Antiviral Chemistry & Chemotherapy 8 (1997) 131-139
26. Neurath A.R., Jiang S., Strick N., Lin K., Li Y.-Y., and Debnath A.K. Bovine β-lactoglobulin modified by 3-hydroxyphthalic anhydride blocks the CD4 receptor for HIV. Nature Medicine 2 (1996) 230-234
27. Neurath A.R., Strick N., and Li Y.-Y. 3-Hydroxyphthaloyl-β-lactoglobulin. III. Antiviral activity against herpes viruses. Antiviral Chemistry & Chemotherapy 9 (1998) 177-184
28. O'Connell J.F., Albin R., Blum D., Grint P., and Schwartz J. Development of antiviral agents for picornavirus infections. In: Rotbart H.A. (Ed). Human enterovirus infections (1995), ASM Press, Washington, DC, USA 419-434
29. Oliveira J.C.R., Montes de Oca H., Duarte M.M., Diniz C.R., and Fortes-Dias C.L. Toxicity of South American snake venoms measured by an in vitro cell culture assay. Toxicon 40 (2002) 321-325
30. Pan Y., Lee A., Wan J., Coventry M.J., Michalski W.P., Shiell B., et al. Antiviral properties of milk proteins and peptides. International Dairy Journal 16 (2006) 1252-1261
31. Pan Y., Wan J., Roginski H., Lee A., Shiell B., Michalski W.P., et al. Comparison of the effects of acylation and amidation on the antimicrobial and antiviral properties of lactoferrin. Letters in Applied Microbiology 44 (2007) 229-234
32. Sandoval I.V., and Carrasco L. Poliovirus infection and expression of the poliovirus protein 2B provoke the disassembly of the Golgi complex, the organelle target for the anti poliovirus drug Ro-090179. Journal of Virology 71 (1997) 4679-4693
33. Schoen P., Corver J., Meijer D.K.F., Wilschut J., and Swart P.J. Inhibition of influenza virus fusion by polyanionic proteins. Biochemical Pharmacology 53 (1997) 995-1003
34. Sitohy M., Chobert J.-M., Gaudin J.-C., and Haertlé T. When positively charged milk proteins can bind to DNA. Journal of Food Biochemistry 26 (2002) 511-532
35. Sitohy M., Chobert J.-M., and Haertlé T. Simplified short-time method for the esterification of milk proteins. Milchwissenschaft 56 (2001) 127-131
36. Sitohy M., Chobert J.-M., and Haertlé T. Esterified whey proteins can protect Lactococcus lactis against bacteriophage infection. Comparison with the effect of native basic proteins and L-polylysines. Journal of Agricultural and Food Chemistry 53 (2005) 3727-3734
37. Sitohy M., Chobert J.-M., Karwowska U., Gozdzicka-Jozefiak A., and Haertlé T. Inhibition of bacteriophage M13 replication with esterified milk proteins. Journal of Agricultural and Food Chemistry 54 (2006) 3800-3806
38. Superti F., Ammendolia M.G., Valenti P., and Seganti L. Antirotaviral activity of milk proteins: Lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29. Medical Microbiology and Immunology 186 (1997) 83-91
39. Swart P.J., Harmsen M.C., Kuipers M.E., Van Dijk A.A., Van der Strate B.W.A., Van Berkel P.H.C., et al. Charge modification of plasma and milk proteins results in antiviral active compounds. Journal of Peptide Science 5 (1999) 563-576
40. Swart P.J., Kuipers M.E., Smit C., Van der Strate B.W.A., Harmsen M.C., and Meijer D.K.F. Lactoferrin: Antiviral activity of lactoferrin. In: Spik G., Legrand D., Mazurier J., Pierce A., and Perraudin J.P. (Eds). Advances in lactoferrin research (1998), Plenum Press, New York, USA 205-213
41. Swart P.J., and Meijer D.K.F. Negatively charged albumins: A novel class of polyanionic proteins with a potent anti-HIV activity. Antiviral News 2 (1994) 69-71
42. Takami M., Sone T., Mizumoto K., Kino K., and Tsunoo H. Maleylated human serum albumin inhibits HIV-1 infection in vitro. Biochimica et Biophysica Acta 1180 (1992) 180-186
43. Villahermosa M.L., Thomson M., Vazquez de Parga E., Cuevas M.T., Contreras G., Perez-Alvarez L., et al. Improved conditions for extraction and amplification of human immunodeficiency virus type 1 RNA from plasma samples with low viral load. Journal of Human Virology 3 (2000) 27-34
44. Vorland L.H. Lactoferrin: A multifunctional glycoprotein. Apmis 107 (1999) 971-981
45. Waarts B., Aneke O.J.C., Smit J.M., Kimata K., Bittman R., Meijer D.K.F., et al. Antiviral activity of human lactoferrin: Inhibition of alphavirus interaction with heparin sulfate. Virology 333 (2005) 284-292
46. Woodruff J.F. Viral myocarditis: A review. American Journal of Pathology 101 (1980) 425-483